Alberto J S Duarte
Overview
Explore the profile of Alberto J S Duarte including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
88
Citations
994
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fink T, Canton A, Pereira M, Bain V, Matsuo O, Astley C, et al.
Clinics (Sao Paulo)
. 2023 Nov;
78:100299.
PMID: 37988857
No abstract available.
2.
Martucci L, Eichler R, Silva R, Costa T, Tostes R, Busatto G, et al.
iScience
. 2023 Aug;
26(9):107542.
PMID: 37636076
Intracellular peptides (InPeps) generated by the orchestrated action of the proteasome and intracellular peptidases have biological and pharmacological significance. Here, human plasma relative concentration of specific InPeps was compared between...
3.
Leal V, Andrade M, Teixeira F, Cambui R, Roa M, Marra L, et al.
Scand J Immunol
. 2022 Dec;
97(3):e13247.
PMID: 36541819
SARS-CoV-2 triggers inflammasome-dependent release of pro-inflammatory cytokine IL-1β and pyroptosis, therefore, contributes to the huge inflammatory response observed in severe COVID-19 patients. Less is known about the engagement of inflammasome...
4.
Leal V, Paulino L, Cambui R, Zupelli T, Yamada S, Oliveira L, et al.
Inflamm Res
. 2022 Nov;
72(10-11):1933-1940.
PMID: 36416944
Objective And Design: The heterogeneity of response to SARS-CoV-2 infection is directly linked to the individual genetic background. Genetic variants of inflammasome-related genes have been pointed as risk factors for...
5.
Silva C, Medeiros-Ribeiro A, Kupa L, Yuki E, G Pasoto S, Saad C, et al.
Nat Commun
. 2022 Oct;
13(1):5801.
PMID: 36192386
The determination of durability and vaccine-associated protection is essential for booster doses strategies, however data on the stability of SARS-CoV-2 immunity are scarce. Here we assess anti-SARS-CoV-2 immunogenicity decay and...
6.
Andrade M, Leal V, Fernandes I, Gozzi-Silva S, Beserra D, Oliveira E, et al.
Antioxidants (Basel)
. 2022 Sep;
11(9).
PMID: 36139764
The formation of microthrombi in lung autopsies indicates the involvement of NETs in the immunopathogenesis of severe COVID-19. Therefore, supplements inhibiting NET formation, in association with drugs with fewer adverse...
7.
Monteiro M, Prates G, de Lima Nascimento N, Veiga A, Magri M, Polis T, et al.
Curr HIV Res
. 2022 Jun;
20(6):457-462.
PMID: 35748552
Introduction: People living with Human Immunodeficiency Virus (HIV) are under risk for co-infection with SARS-CoV-2. This population may be more prone to complications from COVID-19 due to persistent inflammation caused...
8.
Pereira A, Bes T, Velho M, Marques E, Jannes C, Valino K, et al.
Hum Mol Genet
. 2022 Apr;
31(18):3021-3031.
PMID: 35368071
The coronavirus disease 2019 (COVID-19) pandemic has changed the paradigms for disease surveillance and rapid deployment of scientific-based evidence for understanding disease biology, susceptibility and treatment. We have organized a...
9.
Aikawa N, Kupa L, G Pasoto S, Medeiros-Ribeiro A, Yuki E, Saad C, et al.
Lancet Rheumatol
. 2021 Dec;
4(2):e113-e124.
PMID: 34901885
Background: We aimed to examine the immunogenicity pattern induced by the inactivated SARS-CoV-2 vaccine CoronaVac (Sinovac Life Sciences, Beijing, China) in SARS-CoV-2 seropositive patients with autoimmune rheumatic diseases compared with...
10.
Luna-Muschi A, Borges I, de Faria E, Barboza A, Maia F, Leme M, et al.
J Infect
. 2021 Sep;
84(2):248-288.
PMID: 34537321
No abstract available.